Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine-Reference-Cited by-同舟云学术

Personalized Treatment Strategies Effective in Hypertrophic Cardiomyopathy Do Not Rely on Genomics in 2022: A Different Tale of Precision Medicine

Published:2022-11 Issue: Volume:183 Page:150-152
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Maron Barry J.,Maron Martin S.,Sherrid Mark V.,Ommen Steve R.,Rowin Ethan J.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. A new initiative on precision medicine;Collins;N Engl J Med,2015

2. Congress.gov. S.3822 - genomics and personalized medicine act of 2006. Available at: https://www.congress.gov/bill/109th-congress/senate-bill/3822. Accessed on May 5, 2022.

3. Sotorasib for lung cancers with KRASp.G12c mutation;Skoulidies;N Engl J Med,2021

4. ST1571, a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia: validating the promise of molecularly targeted therapy;Mauro;Cancer Chemother Pharmacol,2001

5. The HER-2 receptor and breast cancer: 10 years of targeted anti-HER-2 therapy and personalized medicine;Ross;Oncologist,2009

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023;The American Journal of Cardiology;2024-02

2. Genotype Analysis as a Clinical Tool for Families in Hypertrophic Cardiomyopathy;JACC: Advances;2023-10

3. How common is hypertrophic cardiomyopathy… really?: Disease prevalence revisited 27 years after CARDIA;International Journal of Cardiology;2023-07